Works in Cancer Chemotherapy & Pharmacology, 2005, Vol 56, Issue 5

Results: 13

Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study.

Published in:

2005

By:

Stathopoulos, G. P.;
Tsavdaridis, D.;
Malamos, N. A.;
Rigatos, S. K.;
Kosmas, Ch.;
Pergantas, N.;
Stathopoulos, J. G.;
Xynotroulas, J.

Publication type:

journal article

Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 492, doi. 10.1007/s00280-005-1015-2

By:

Muindi, Josephia R.;
Potter, Douglas M.;
Yibing Peng;
Johnson, Candace S.;
Trump, Donald L.

Publication type:

Article

Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 510, doi. 10.1007/s00280-005-1028-x

By:

Zagon, Ian S.;
Jaglowski, Jeffrey R.;
Verderame, Michael F.;
Smith, Jill P.;
Leure-duPree, Alphonse E.;
McLaughlin, Patricia J.

Publication type:

Article

Augmenting tumor sensitivity to topotecan by transient hypoxia.

Published in:

2005

By:

Lund, Eva L.;
Hansen, Lasse T.;
Kristjansen, Paul E. G.

Publication type:

journal article

Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 497, doi. 10.1007/s00280-005-1001-8

By:

Darvari, Ramin;
Boroujerdi, Mehdi

Publication type:

Article

Magnesium depletion enhances cisplatin-induced nephrotoxicity.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 535, doi. 10.1007/s00280-005-1010-7

By:

Lajer, H.;
Kristensen, M.;
Hansen, H. H.;
Nielsen, S.;
Frøkiær, J.;
Østergaard, L. F.;
Christensen, S.;
Daugaard, G.;
Jonassen, T. E. N.

Publication type:

Article

Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.

Published in:

2005

By:

Briasoulis, E.;
Samantas, E.;
Kalofonos, H.;
Skarlos, D.;
Makatsoris, T.;
Christodoulou, C.;
Fountzilas, G.;
Bamias, A.;
Dimopoulos, M.A.;
Kosmidis, P.;
Pavlidis, N.

Publication type:

journal article

Biweekly oxaliplatin combined with oral capecitabine (OXXEL regimen) as first-line treatment of metastatic colorectal cancer patients: a Southern Italy Cooperative Oncology Group phase II study.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 481, doi. 10.1007/s00280-005-1003-6

By:

Comella, P.;
Massidda, B.;
Palmeri, S.;
Farris, A.;
De Lucia, L.;
Natale, D.;
Maiorino, L.;
Tafuto, S.;
De Cataldis, G.;
Casaretti, R.

Publication type:

Article

S-phase modulation by irinotecan: pilot studies in advanced solid tumors.

Published in:

2005

By:

Ramnath, N.;
Khushalani, N.;
Toth, K.;
Litwin, A. M.;
Intengan, M. E.;
Slocum, H. K.;
Pendyala, L.;
Smith, P. F.;
Stewart, C. C.;
Hoffman, J. L.;
Javle, M. M.;
Berdzik, J.;
Creaven, P. J.;
Rustum, Y. M.

Publication type:

journal article

Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 465, doi. 10.1007/s00280-005-1018-z

By:

Yawata, Ayako;
Su-Ryang Kim;
Miyajima, Atsuko;
Kubo, Takashi;
Ishida, Seiichi;
Saito, Yoshiro;
Nakajima, Yukiko;
Katori, Noriko;
Matsumoto, Yoshiaki;
Fukuoka, Masamichi;
Ohno, Yasuo;
Ozawa, Shogo;
Sawada, Jun-ichi

Publication type:

Article

Spectrophotometric investigation of the chemical compatibility of the anticancer drugs irinotecan-HCl and epirubicin-HCl in the same infusion solution.

Published in:

2005

By:

Ozdemir, Filiz Arioz;
Anilanmert, Beril;
Pekin, Mursit

Publication type:

journal article

Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 455, doi. 10.1007/s00280-005-1022-3

By:

Luo, F. R.;
Yang, Z.;
Dong, H.;
Camuso, A.;
McGlinchey, K.;
Fager, K.;
Flefleh, C.;
Kan, D.;
Inigo, I.;
Castaneda, S.;
Rose, W. C.;
Kramer, R. A.;
Wild, R.;
Lee, F. Y.

Publication type:

Article

Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor β expression in head and neck squamous carcinoma (HNSCC) cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 56, n. 5, p. 543, doi. 10.1007/s00280-004-0970-3

By:

Young Mi Whang;
Eun Jung Choi;
Jae Hong Seo;
Jun Suk Kim;
Young Do Yoo;
Yeul Hong Kim

Publication type:

Article